Media OutReach
HKUST Announces the Appointment of Prof. King Li as the Founding Dean of Medicine
Following a rigorous global search, Prof. Li was selected for his exceptional track record in academic leadership, medical education, and biomedical innovation, as well as his unique experience in founding a new medical school.
Prof. Li previously served as Founding Dean of the Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign (UIUC) from 2016 to 2021—one of the world’s pioneering engineering-based medical schools. During his tenure, he played a pivotal role in developing a technology-oriented curriculum, recruiting founding faculty, and building academic-clinical partnerships. Under his leadership, the College’s early graduating cohorts achieved a 100% pass rate in licensing examinations, reflecting the outstanding quality and rigorous standards of the programme.
An internationally distinguished physician-scientist and biomedical innovator, Prof. Li currently holds the titles of Dean Emeritus and Professor Emeritus at the Carle Illinois College of Medicine, as well as Adjunct Professor of Radiology at Stanford University School of Medicine. His career spans leading institutions including Stanford University, the U.S. National Institutes of Health, Weill Cornell Medical College, Wake Forest School of Medicine, and UIUC. He holds a Doctor of Medicine (with Honours) from the University of Toronto and an MBA from San José State University.
Prof. Li’s appointment comes at a pivotal moment as HKUST advances its plans to establish a new School of Medicine. The School will offer a four-year graduate-entry MBBS programme, with its inaugural cohort expected to commence in the 2028/29 academic year.
His experience aligns closely with HKUST’s vision to develop a future-ready medical school that integrates clinical excellence with engineering, data science, and emerging technologies. His proven approach to training physician-innovators—combining strong clinical foundations with interdisciplinary expertise—will provide a robust foundation for the School’s development, while being adapted to HKUST’s unique strengths in science and technology.
Known for his commitment to interdisciplinary collaboration, Prof. Li has consistently bridged fields such as radiology, bioengineering, computer science, and nanotechnology—an approach that will be instrumental in shaping HKUST’s innovative model of medical education.
Beyond medical education, Prof. Li is a highly accomplished innovator. He is a Fellow of the US National Academy of Inventors and has received the Gold Medal of the Association of University Radiologists. He is also a Fellow of several leading professional bodies, including the American College of Radiology, the American Institute for Medical and Biological Engineering, and the International Society for Magnetic Resonance in Medicine. He holds 20 issued patents across the United States, Australia, and Europe, and has founded a company based on his translational research.
Prof. Harry SHUM, Chairman of HKUST Council, said, “I would like to extend my warmest welcome to Prof. Li on his appointment as our Founding Dean of the School of Medicine. His proven expertise and experience are invaluable to the University as we plan to develop a distinctive model of medical education for the future. We have full confidence in his exceptional leadership in spearheading our medical school, which is one of the most significant undertakings in HKUST’s 35‑year history. The Council is committed to giving its support to ensure the success of the School.”
Prof. Nancy IP, President of HKUST, said, “Prof. Li brings a rare combination of founding dean experience, academic excellence, and a forward-looking vision for technology-driven medical education. His leadership will be central to building a medical school that is globally competitive, locally relevant, and impactful for Hong Kong and the wider region. We warmly welcome Prof. Li to the University and look forward to his leadership in the establishment of the HKUST School of Medicine, as well as in shaping a new generation of medical professionals and advancing innovation in healthcare. I also extend our sincere appreciation to the Search Committee, chaired by Ms. Edith SHIH (Vice-Chairperson of the Council), and its members including Prof. FOK Tai-Fai and Prof. Raymond LIANG for their dedication and diligence in completing this important international recruitment process.”
Prof. King Li, Founding Dean of the School of Medicine, said,”I am deeply honoured to be appointed as the Founding Dean of HKUST’s new School of Medicine. Returning to Hong Kong—where my roots are—to take on this role at HKUST and having the chance to give back through the place I grew up, is deeply meaningful to me. HKUST has a remarkable track record of turning bold visions into reality, and I am excited to build a medical school that reimagines physician training through the integration of engineering, data science, and biomedical innovation. Drawing on my experience and working closely with our partners in Hong Kong and the Greater Bay Area, I look forward to nurturing a new generation of physician-innovators who will transform healthcare for the benefit of patients and society.”
Born and raised in Hong Kong, Prof. Li brings with him a strong personal commitment to advancing Hong Kong as an international hub for medical education and innovation. He has long-standing ties with the local academic and medical communities.
The University community is expected to provide its full support to Prof. Li as he expands partnerships with teaching hospitals, the government, industry, and the global medical community, and further strengthens connections with the Greater Bay Area and other regions.
Hashtag: #HKUST
The issuer is solely responsible for the content of this announcement.
About The Hong Kong University of Science and Technology
The Hong Kong University of Science and Technology (HKUST) (
https://hkust.edu.hk/) is a world-class university known for its innovative education, research excellence, and impactful knowledge transfer. With a holistic and interdisciplinary pedagogy approach, HKUST was ranked 6th in the QS Asia University Rankings 2026, 3rd in the Times Higher Education’s Young University Rankings 2024, and 19th globally and 1st in Hong Kong in the Times Higher Education’s Impact Rankings 2025. Eleven HKUST subjects were ranked among the world’s top 50 in the QS World University Rankings by Subject 2026. In addition, in the Times Higher Education World University Rankings by Subject 2026, HKUST’s Computer Science discipline which encompasses areas such as artificial intelligence and machine learning, has been ranked No. 1 in Hong Kong for ten consecutive years. Our graduates are highly competitive, consistently ranking among the world’s top 30 most sought-after employees. In terms of research and entrepreneurship, over 80% of our work was rated “internationally excellent” or “world leading” in the Research Assessment Exercise 2020 of the Hong Kong’s University Grants Committee. As of May 2026, HKUST members have founded over 1,900 active start-ups, including 11 Unicorns and 22 exits (IPO or M&A).
Media OutReach
Global Wellness Forum 2026 Set for June 23 in Kuala Lumpur as Malaysia’s Nutraceutical Industry Embarks on Next-Gen Transformation
As a core component, James Pereira, general manager of MADSA, will share insights on Malaysian health industry regulations. Adrian Toh, CEO & Executive Director of R Pharmacy, will provide frontline retail channel observations regarding shifting consumer demands. Alex Liao, General Manager of Welbloom Bio-Tech, will represent Taiwan to share how format innovation effectively responds to brand differentiation, consumption experiences, and market compliance needs.
Faced with brands’ attention toward differentiated experiences, Welbloom Bio-Tech will showcase its proprietary, Halal-certified FRESH-Jelly® technology on-site, demonstrating the innovative application to make supplements more food-like. Through ingredient payload capacities, zero- or low-sugar designs, and customized flavor development, FRESH-Jelly® allows supplements to maintain functionality while becoming more enjoyable to consume regularly, providing Malaysian brands with a distinctive option beyond capsules and tablets.
With the rapid rise of Malaysia’s wellness consumer market, its mature distribution channels and exceptional potential for regional expansion are accelerating the country’s growth as a critical hub for the Southeast Asian health industry. Welbloom Bio-Tech states that this forum is a bridging platform connecting Taiwan’s manufacturing capabilities with Malaysian market insights, aiming to unlock commercially viable partnerships for both regions.
The event is organized by The PAGE, co-organized by Welbloom Bio-Tech and SEAbizs, and supported by NTBSA, MATRADE, R Pharmacy, and MADSA.
【Event Information】
Time: June 23, 2026, 09:30 – 14:00
Venue: The Zenith – Connexion Conference & Event Centre, Kuala Lumpur
Hashtag: #WelbloomBioTech
The issuer is solely responsible for the content of this announcement.
About Welbloom Bio-Tech
Welbloom Bio-Tech focuses on health supplement R&D, manufacturing, and dosage form innovation. Through forward-looking market foresight and robust R&D technologies, it provides one-stop services from formulation design and flavor development to manufacturing, assisting clients in Malaysia and Singapore to build highly competitive health supplements.
To learn more, please search “Welbloom” or click the link:
https://welbloom.com/malaysiaforum2026/
Media OutReach
Doing Good Index 2026: Asia’s US$753 Billion Philanthropic Potential Remains Unrealized
- Asia’s social sector is under strain: 78% of the 2,166 social delivery organizations (SDOs) surveyed report insufficient domestic funding.
- Asia is one of the fastest-growing regions for wealth creation, yet the policies and incentives needed to channel it toward social good are not keeping pace.
- Singapore has become the first economy to enter the “Doing Excellent” category, demonstrating what alignment across regulations, tax incentives, government partnerships and efforts to create a culture of giving can achieve.
- 84% of Asian SDOs surveyed apply the UN Sustainable Development Goals (SDGs) in their operations, pointing to their enduring value as a shared framework for coordination and collective action beyond 2030.
HONG KONG SAR – Media OutReach Newswire – 16 June 2026 – Asia’s social needs are intensifying, and official development assistance is declining. Yet, while the region’s wealth is growing dramatically, the policies, incentives and partnerships needed to channel private capital toward social good are not keeping pace. That is a key finding of the Doing Good Index 2026, the fifth edition of CAPS’s flagship policy report, which assesses the enabling environment for private social investment across 17 Asian economies.
The report finds that while the enabling environment for private social investment is in place across much of the region, its effectiveness remains uneven. Improvements in registration processes and accountability mechanisms have been accompanied by persistent barriers, including restrictions on foreign funding, regulatory complexity, and inconsistent government engagement. In many cases, policies exist on paper but are not fully implemented in practice, limiting their impact.
At the same time, although trust in SDOs remains high across the region, broader ecosystem conditions, such as media sentiment, talent pipelines, and institutional support, are showing signs of strain. 81% of SDOs struggle to secure unrestricted funds for their work, while 73% report difficulty recruiting staff, constraining the sector’s ability to turn trust into impact.
“Asia has the wealth, the will, and in many economies, the foundations of a strong enabling environment. What is needed now is concerted, aligned effort to bring them together. The potential is enormous,” said Ruth Shapiro, Co-Founder and CEO, Centre for Asian Philanthropy and Society.
Even as Asia’s wealth continues to grow, the region faces significant and intensifying challenges across climate, education and health. Official development assistance is declining, and there is increasing pressure on domestic resources at precisely the moment demand for social services is rising.
If Asian economies were to contribute just 2% of GDP to philanthropy, as the United States does, it could generate an estimated US$753 billion annually for social good. That represents 15 times the official development assistance flowing into the region, and almost half the financing needed to hit the UN’s SDGs in Asia. But realizing that potential depends on strengthening the policies, incentives and partnerships that enable private capital to flow toward social good. The Doing Good Index 2026 finds that across much of Asia, those conditions are not yet in place.
“The world has changed dramatically, and Asia can no longer rely on others to address its social challenges. The Doing Good Index 2026 shows the region has the potential to meet this moment, but only if governments and philanthropists act together to build the conditions that make it possible,” said Ronnie Chan, Chairman, Centre for Asian Philanthropy and Society.
Singapore Shows What Alignment Can Achieve
Singapore has, for the first time, entered the top “Doing Excellent” category in the Doing Good Index 2026, reflecting years of deliberate effort to build a strong culture of philanthropy and civic engagement. Clear regulations, generous tax incentives, openness to foreign funding, and close collaboration between government and the social sector have created a strong enabling environment.
Singapore’s achievement demonstrates that when regulations, fiscal policy, ecosystem conditions and procurement work in concert, the outcomes are stronger. While no two economies will follow the same path, Singapore’s experience highlights the conditions that matter, such as the active promotion and alignment of philanthropy and giving across the whole of society.
The SDGs: Falling Short but Still Relevant in Asia
In the run-up to 2030, global progress toward the SDGs has fallen short of ambition, and Asia is no exception. Yet the Doing Good Index 2026 finds that 84% of SDOs continue to apply the SDGs in their work. Further, the rise of Environmental, Social and Governance (ESG) reporting has not displaced them, because most SDOs see the two frameworks as complementary rather than competing.
As the deadline approaches, the Index points to their enduring value not as a target but as a shared framework for strategy, coordination and collective action in the years ahead.
Other Findings from the Report
- Talent shortages persist for Asia’s social sector: more than 70% of SDOs face difficulty recruiting and retaining staff across Asia.
- AI adoption is happening, but usage remains limited: only 13% of surveyed SDOs report using AI regularly.
- 39% of SDOs say claiming tax benefits is difficult, suggesting administrative barriers may be limiting the impact of existing incentives for giving.
Hashtag: #CAPS #DoingGood #PrivateCapital #PublicGood #Philanthropy #Impact
The issuer is solely responsible for the content of this announcement.
About the Doing Good Index
Released biennially and now in its fifth edition, the Doing Good Index is CAPS’s flagship policy research that assesses the enabling environment for doing good in Asia: the systems, policies and practices that facilitate or constrain philanthropic giving and the deployment of this capital.
CAPS’s research team surveyed 2,166 social delivery organizations (SDOs) and conducted 132 interviews with sector experts across 17 Asian economies to provide a comparative, evidence-based view of where environments are supportive, where gaps persist, and how systems can be strengthened to better mobilize private resources for public good.
The Index looks at indicators under four sub-indexes: regulations, tax and fiscal policy, ecosystem, and government procurement, which provide an understanding of the specific measures economies have taken to catalyze philanthropic giving and promote social sector development.
Since its inception, the Index has been an essential resource for policymakers, philanthropists, and nonprofit leaders seeking to understand and improve the conditions for giving across the region.
For more information, 
download the report and visit the Doing Good Index 2026 dedicated microsite.
About the Centre for Asian Philanthropy and Society (CAPS)
Established in 2013 and working across more than 17 economies in Asia, the Centre for Asian Philanthropy and Society (CAPS) is a nonprofit organization committed to improving the quantity and quality of philanthropic and private giving throughout Asia. Our mission is to maximize private capital for public good, conducting research, advisory, convening and capacity building to engage philanthropists, foundations, family offices, corporates, government bodies, social sector organizations and experts on best practices, models, policies and strategies to facilitate private giving and social investment in the region. For more information, visit www.caps.org and 
LinkedIn.
Rise vGPU + ModelHub Power China’s AI into the Heterogeneous Orchestration Era
HONG KONG SAR – Media OutReach Newswire – 15 June 2026 – Frost & Sullivan, a globally renowned growth consulting firm, has released its “2026 AI Infrastructure Orchestration Platform White Paper”. The report recognizes Phancy Group’s Rise vGPU as a Tier 1 Leading Platform, the highest maturity tier in heterogeneous GPU orchestration. Phancy’s ModelHub also achieved the highest Overall Score in the enterprise-grade model management platform evaluation. This marks a significant endorsement of Phancy’s technological capability in heterogeneous AI infrastructure.
According to the white paper, as large model applications scale rapidly, China’s AI industry is facing structural challenges stemming from multi-chip coexistence. These include hardware heterogeneity, fragmented software stacks, persistently low GPU utilization (generally below 30%), and rising model adaptation complexity — all of which have become major bottlenecks for enterprise-scale AI deployment.
The report highlights a fundamental shift in AI infrastructure competitiveness – moving away from “single-chip performance” toward “cluster-scale system coordination.” At this critical juncture, Phancy has positioned itself as a leader in advanced orchestration through its full-stack AI infrastructure platform, offering a proven solution to heterogeneous compute challenges and helping drive China’s AI industry from “compute accumulation” into a new era of “compute orchestration.”
Phancy Rise vGPU: Tier 1 Leading Platform
In its assessment of mainstream AI infrastructure platforms, Frost & Sullivan defined Tier 1 criteria across three core dimensions: heterogeneous support, fine-grained control, and production-grade execution. Phancy Rise vGPU meets all three standards and has been recognized as a Tier 1 Leading Platform.
Rise vGPU transforms AI infrastructure from fragmented, low-efficiency device-level management to a unified software-defined control plane. Its key technology breakthroughs include:
- Comprehensive Heterogeneous Management: Unified onboarding and management across more than 10 mainstream GPU/NPU vendors, including NVIDIA, Ascend, Cambricon, Hygon, and others.
- Ultra-Fine Resource Partitioning: Industry-leading sub-GPU level compute and MB-level memory granularity slicing.
- Significant Utilization Improvement: Through safe oversubscription and time/space multiplexing, GPU utilization is increased from industry averages below 30% to 70%-90%.
- Intelligent Precision Scheduling: Multi-dimensional scheduling algorithms based on priority, topology, load, and resource awareness to achieve optimal compute allocation.
- Production-Grade SLA Assurance: The Deterministic Execution Layer delivers committed and auditable SLA guarantees for critical inference workloads.
- Full Lifecycle Operability: Comprehensive monitoring, metering, and cost allocation capabilities that turn GPU resources into truly operable digital assets.
Model Hub: Highest Overall Score in Model Management Platform Evaluation
Beyond compute orchestration, the report underscores the strategic importance of enterprise-grade model management platforms. As a powerful complement to Rise vGPU, Phancy ModelHub enables enterprises to build a complete full-stack AI infrastructure — from compute to models and from resource scheduling to business delivery.
The white paper notes that Phancy ModelHub delivers leading performance in key areas such as Model & Chip Compatibility, Execution Stability & Performance, and Model-GPU Coordination & Scheduling, achieving the highest Overall Score. Through its unified model management and execution platform, ModelHub creates a seamless closed-loop process covering model onboarding, deployment optimization, inference services, and version governance — significantly lowering the barrier to model deployment and accelerating AI innovation.
Dr. Dai Wenyuan, Founder & CEO of Phancy, said: “The Frost & Sullivan white paper accurately captures the inflection point in AI infrastructure development. The recognition of Rise vGPU as a Tier 1 Leading Platform and ModelHub’s top Overall Score provide important authoritative validation of Phancy’s technology strategy and product strength. As a full-stack AI cloud service platform, Phancy believes the next wave of competitiveness in the AI industry will come from systematic improvements in compute orchestration efficiency. We will continue to focus on heterogeneous compute unified scheduling and model ecosystem operations, working closely with customers and industry partners to advance China’s AI industry from ‘compute accumulation’ to a true ‘compute orchestration’ era.”
Hashtag: #PhancyGroup
The issuer is solely responsible for the content of this announcement.
About Phancy Group
Phancy Group (6682.HK) is a leading full-stack AI cloud services platform, providing comprehensive solutions for the AI 2.0 era. Our offerings include Rise vGPU, ModelHub and SageAIOS, delivering efficient and scalable AI infrastructure with end-to-end capabilities. We provide a complete solution from heterogeneous compute resource management and optimization to the deployment of intelligent agent models. These solutions empower digital transformation across a wide range of industries, supporting our vision of building a large-scale and efficient “Token Factory.”
Guided by the mission of “AI for Everyone” and positioned as the “Navigator of AI,” Phancy Group is committed to becoming a global leader in Artificial General Intelligence.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn